Diagnos Laboratorium Utama Tbk. vs Prima Cakrawala Abadi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Prima Cakrawala Abadi Tbk. trades at Rp41 (market cap 50.17B, 2.04M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 6.4× Prima Cakrawala Abadi Tbk.'s market cap, and Prima Cakrawala Abadi Tbk. is more actively traded (2.04M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | PCAR | |
|---|---|---|
Market Cap | 319B | 50.17B |
Volume | 7.6K | 2.04M |
Lot | 76 | 20.39K |
Turnover | 1.74M | 83.65M |
Average Price | 229.21 | 41.03 |
Value | 1.74M | 83.65M |
Indicative Equilibrium Price | 232 | 41 |
Indicative Equilibrium Volume | 200 | 20.05K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →The Company was established with the name of PT Prima Abadi is a limited company that was established based on the deed of establishment Limited Company PT Prima Cakrawala Abadi No. 111 issued on January 29 2014. The Articles of Association of the company has been experiencing some changes, the updated was the Decision of the Shareholders No. 20 issued on September 19, 2017. The company started commercial business activities in the year 2014.
Read more on PCAR →